A ping list dedicated to exposing the quality, safety and security issues of anything “Made in China”.
Please FReepmail me if you would like to be on or off of the list.
(This can be a high volume ping list.)
Posted on 09/27/2008 3:23:11 PM PDT by nickcarraway
When are the powers in the Food Safety department going to publish all the Chinese products we ingest as ‘food’?
So we will live another day to vote.
According to obama during the Olympics China was something we should aspire to be like. Lead by example and eat the candy first Barack. Then tell us how progressive and palatable China is.
In the most heavily regulated (repressed) society in the world outside of NK the government cannot even keep the food supply safe. So much for government doing a better job than the private sector.
Ping.
I’ve been wondering just how much of this tainted food is making it to our shores.
For all we hear about what’s going on overseas, there’s not much information about what kind of risk the US is at.
Do you have a link to a video or anything of Obama saying that? I sure would like to pass it around.
No. It was during the Olympics though. He praised China and as I recall said we should emulate China as if they had put together modern, gleaming cities (Potemkin villages really) that were/worked better than the US. I do not have any direct quotes, but I am sure a review of articles from that time period would help.
Rat poison in candy ping.
Is Queensway Foods Company the same company that put out the Osama WTC candy? Or am I mistaken?
That is really high. In S. Korea, some snacks contained mid-200 ppm of melamine, and it created a furor. I think 520ppm is about the range baby milk inside China is said to have.
Link: http://www.foodnara.go.kr/portal/site/kfdaportal/melaminedanger/
The information is in Korean. So I suppose it won't be much help.
The maker of White Rabbit candy - a candy given to US president Richard Nixon on a landmark 1972 trip - announced it was halting domestic sales after its products were found to contain melamine, a chemical used to make plastic.
FDA http://www.fda.gov/oc/po/firmrecalls/qfco09_08.html
QFCO, Inc. Recalls White Rabbit Candy Because of Possible Health Risk
Contact: QFCO, Inc.
650-697-6633
FOR IMMEDIATE RELEASE -- September 26, 2008 -- QFCO, Inc. of Burlingame, California is recalling White Rabbit Candy because it may be contaminated with Melamine.
Product was distributed to the states of CA, GA, HI, IL, MN, NY, OR, TX, WA through wholesale distributors to retail stores.
The White Rabbit Creamy Candy is sold in 8 or 16 oz packages. All other flavors of White Rabbit Candy, including Assorted (Chocolate, Coconut, and Coffee), Red Bean, Coffee, Corn, Lychee, Mango and Strawberry are sold in 7 oz. packages. All packaging has a logo of a white rabbit on the front with the words "White Rabbit".
No illnesses associated with this product have been reported to date.
The recall was initiated after it was discovered that product was contaminated with Melamine.
Consumers who have purchased White Rabbit Candy are urged to return it to the place of purchase for a full refund or discard it in their trash. Consumers with questions may contact the company at (650) 697-6633.
The product is manufactured in Shanghai by Shanghai Guan Sheng Yuan Food, Ltd.
Shanghai Guan Sheng Yuan International Trade Co.,Ltd.
They make:
candy, honey, Chinese wine, gourmet powder, seasoning, frozen food, noodle, cookies, soup, fried rice
They own: National Famous Trade Marks “Guan Sheng Yuan” and “White Rabbit” and Municipal Famous Trade Marks “Sheng”, “Hua Tuo”, “Fo Shou”, etc.. Guan Sheng Yuan (Group) Co., Ltd., “Fo Shou” brand of gourmet power; “Guan Sheng Yuan” brand of seasonings, frozen food, and wheat products, “Hua Tuo” brand of tonic wine (including “He” brand of wine); “Sheng” brand of honey; and other products.
Obviously this must be just an excerpt. This company is huge and we aren’t finding out the extend of the tainted products because of the global reach AND the custom branding.
These raw materials reach into the food and medical products.
History
2007
Announced a strategic alliance with Kirin Group.
Established Mumbai Liaison Office in India.
Licensed “COMPLEGENTTM”, a novel antibody technology that enhances the activity of antibodies, to BioWa.
Launched Topina, an anti-epileptic agent.
Made Daiichi Fine Chemical Co., Ltd. a subsidiary.
Launched Remake Citrulline, a supplement, and L-Citrulline, a raw material for food.
Established Shanghai Representative Office of Kyowa Hakko Chemical Co., Ltd.
Launched SOFTTO series, a new material for baking that softens the bread.
Established a new plant for liquid seasonings at Tsuchiura Plant of Kyowa Hakko Food Specialties Co., Ltd.
Established Qingdao Kyowa Wanfu Foods Co., Ltd. as a new base for production of freeze dried foods.
2006
Launched Patanol, anti-allergic eye drops.
Launched Bothdel, an MRI contrast medium for the gastrointestinal tract.
Launched Metabolead, a diagnostic reagent for remnant lipoproteins-cholesterol.
BioWa, Inc. licensed “POTELLIGENT®” antibody technology to Genentech, Inc.
Launched Kyowa’s fermentation CoQ10, made from plant-derived material.
Invented the world’s first fermentation-based process of L-tyrosine mass production.
Shanghai Kyowa Amino Acid Co., Ltd. established new amino acids production facilities.
Kyowa Foods (Jiangyin) Co., Ltd. established new seasonings production facilities.
Kyowa FD Foods began to sell freeze dried soups by mail order.
2005
Completed the transition to an operating holding company; pharmaceuticals and bio-chemicals are its twin pillars.
Spun off its food business,establishing Kyowa Hakko Food Specialties Co.,Ltd.
Refined the CI mark (Started a new Corporate Branding Program).
Set up BioFrontier Laboratories by integrating former BioFrontier Laboratories with Tokyo Research Laboratories.
Received the Kei Arima Memorial Japan Bioindustry Association Award for the development of the innovative “POTELLIGENT®” antibody technology, which greatly enhances certain antibody activity.
Launched plant-based glucosamine produced by fermentation (a Japan first).
Launched DIYA YEAST VS (low temperature inactive multipurpose yeast).
2004
Second plant put into operation at Wuxi Xiehe Food Co.,Ltd.,a natural seasoning production and sales subsidiary in China.
Launched Kokumi Seasonings MP-300 for processed food manufacture.
Launched Ox-LDL reagent MX for research use.
Transferred all capital of Agroferm Hungarian-Japanese Fermentation Industry Ltd. to Degussa AG.
Finding koku of foods from mature cheese.
Kyowa Yuka Co.,Ltd.,a production subsidaiary of Kyowa Hakko, succeeded its Chemicals operation and made a new start as Kyowa Hakko Chemical Co., Ltd.
2003
Transferred all capital of Fermentaciones Mexicanas, S.A de C.V. (Fermex) to SAFMEX, S.A. C.V.
Established Japan Ethyl Acetate Co., Ltd. a joint venture with Showa Denko K.K. for the production of ethyl acetate.
Launched Remake GABA (?-aminobutyric acid, health food).
Launched Kokumi Seasonings CP-200 for processed food manufacture.
Launched Desmopressin Spray 10 Kyowa, a treatment for nocturnal enuresis.
Launched Determiner R BNP, a high sensitivity BNP diagnostic agent for cardiovascular disease.
Established BioWa, Inc. in the United States to promote Kyowa Hakko?s biopharmaceutical business.
Launched DIYA YEAST PBX (antifungal yeast).
Launched DOBUPOM Injection syringe (acute circulatory failure agent).
2002
Launched Inovan Injection syringe (acute circulatory failure agent).
Launched a reagent exclusively for fully automated biochemistry analyzer Modular Analytics Series.
Established Yantai Kyowa Foods Co., Ltd. in China to produce freeze-dried foods.
Succeeded in industrial production of 2,4-Diethylglutaric Acid, a dicarboxylic acid for fine chemicals and electronics use.
Transferred all capital of Mohan Medicine Research Institute to Merck Hoei Ltd.
Launched Durotep, a transdermal analgesic for persistent pain associated with cancer.
Transferred alcoholic beverage business to Asahi Breweries Ltd.
2001
Launched Choleste-block (specially designed health food for lowering cholesterol) and Allelock (an anti-allergic agent).
Initiated the CSMAX21 system to improve business quality
Launched CSPHP tablets made from main ingredients of Choleste-block.
Developed an innovative antibody technology that greatly enhances antibody activity.
Terminated joint business with Johnson & Johnson (transferred all Kyowa’s capital to Janssen Pharmaceutical, Inc.).
2000Established J Plus Co., Ltd., a joint venture for the plasticizers business.
Established a food sales base, Kyowa Foods (H.K) Co., Ltd.
Launched Nishikiaji Junmai and Nishikiaji Nikiri (brewed seasonings for business use).
Developed the commercial production process of oligosaccharides by fermentation.
Launched additive-free organic wine, Shitamachi Fumi Super Lemon and Ginrei Genkai (wheat yeast shochu).
1999
Developed the EXLUB external lubrication tableting system.
Established Kyowa America, Inc., a holding company, in the USA.
Launched Sainte Neige Wine, Class d’Or.
Completed an investigational drug production facility in Sakai Research Laboratories.
Launched Sainte Neige Wine Vin Organic series.
Launched Navelbine, an anticancer agent.
Completed pharmacokinetic research facility in Pharmaceutical Research Institute.
Introduced the In-House Company System (Pharmaceuticals, Bio-Chemicals, Chemicals, Liquor & Alcohol and Food), along with the Executive Officers System.
Established Wuxi Xiehe Food Co., Ltd.
Determined the whole genome sequence of Corynebacterium glutamicum.
Launched Meditransnitro, a transdermal nitroglycerin product.
Launched a jointly developed hair-growing agent Medicated Mohkatsurin PB from FANCL Corp.
1998
Established a system to recycle drugs from shochu production.
Completed quality management facility in Fuji Plant.
Started the marketing of Navoban, an oral anti-emetic.
Launched Kokumi Seasonings HS-100 and BS-100.
Launched canned low alcohol beverages, Shitamachi Fumi Chuhai.
Established Shanghai Guan Sheng Yuan Kyowa Amino Acid Co., Ltd.
Launched BiGlex (a bread and cake improver) and Multi-Vitamin & Mineral supplements (health food).
1997
Began operations of Medical Ube Distribution Center.
Launched Imagenil, a non-ionic X-ray contrast medium.
Launched Daigoro shochu (4-liter) throughout Japan.
Received the Kei Arima Memorial Japan Bioindustry Association Award for the development of a new production method for hydroxyproline.
Kyowa Yuka Co., Ltd. established a production facility for synthetic fatty acids.
1996
Launched Tanrei Awamori, Asian.
1995
Consolidated Kyowa Plant Koji Co., Ltd. and KF Engineering Co., Ltd. to launch Kyowa Engineering Co., Ltd.
Completed a new building for innovative formulation research in Pharmaceutical Research Institute.
Launched Kanoka wheat shochu throughout Japan.
Invested in Asahi Food Products Co., Ltd., a flour manufacturer.
Established DINAVEC Research, Inc.
Launched Sainte Neige Wine, Grande.
1994
Launched low-temperature-resistant yeast for bread production.
Operated Medical Tokyo Distribution Center.
Launched Neu-up, a recombinant human G-CSF derivative.
Obtained approval for the additional indication of renoparenchymal hypertension for Coniel.
Launched Determiner HDL-C, a diagnostic reagent for HDL cholesterol.
1993
Began drug sales in the UK.
Launched Itrizole, an oral antimycotic agent.
Completed a new building in the Technical Research Laboratories.
Launched Kanoka, wheat shochu, in Chugoku, Shikoku and Kyushu areas.
Launched Nizoral, an antimycotic agent for external use.
Completed a production facility for synthetic manufacture of bulk pharmaceuticals in Yokkaichi.
1992
Established Kyowa Pharmaceutical, Inc. in the USA.
Launched Determiner L (a liquid reagent) and Wine Kazoku (Sainte Neige Wine).
Expanded Kyowa Yuka oxoalcohol production facility and established a plasticizer DINP facility.
1991
Merger of Kyowa Yuka Co., Ltd. and Japan Oxocol Co., Ltd.
Launched Depakene R (an anti-epileptic agent), Activacin (a thrombolytic agent), and Coniel (a remedy for hypertension and angina pectoris).
Established drug manufacturing facilities in Ube Plant.
Opened the Food Creation Center (FCC).
Operated Lysine production facilities in Agroferm Hungarian-Japanese Fermentation Industry Ltd.
Established Representative Offices in Budapest and Shanghai.
1990
Established Medical Representative Offices in New York and Dusseldorf, as drug development bases.
Completed construction of Kyowa Medex Fuji manufacturing facilities and research laboratories.
1989
Completed Tsukuba Research Laboratories.
Established Kyowa Hakko (H.K.) Co., Ltd.
Launched Farmorubicin (an anticancer agent) and Acenalin (a gastroprokinetic agent).
Established Kyowa Iryo Kaihatsu Co., Ltd.
Established a company for research and development, Nutri-Quest, Inc. in Missouri, USA.
Acquired all stocks of Shinwa Pharmaceutical Co., Ltd., a company that produces and sells kampoyaku (Chinese traditional medicine).
1988
Concluded a tie-up contract with Farmitalia Carlo Erba.
Established Japan Oxocol Co., Ltd. to strengthen the plasticizers business.
Launched Mebendazole, an anthelmintic agent, from Janssen-Kyowa Co., Ltd.
Established Beijing Representative Office.
Launched Desmopressin Injection 4 Kyowa, a hemostatic control agent.
Established Kato Memorial Bioscience Foundation.
1987
Launched Hysron H 200 (an anticancer agent), Celtect (an anti-allergic agent), Neoperidol (an antipsychotic agent), Buson (barley shochu) and Honkakuha Tamago Soup (the instant egg-drop soup for business use).
Established Agroferm Hungarian-Japanese Fermentation Industry Ltd., a consolidated company in Hungary.
1986
Launched EL-1000, an automated immunochemical analyzer.
Launched Dacarbazine, an anticancer agent.
1985
Launched SunShower, low-alcohol beverages.
Launched Fortimicin, an antibiotic agent.
Established Kyowa Hakko (Thailand) Ltd.
Launched Kyowa Hakko Diya, and Daigoro (2.7 liter) shochu.
1984
Completed the Seifu Building, the company’s own building, in Nagoya.
Established Biokyowa Inc. in Missouri, USA, for the production of amino acids.
Launched Lubby (yeast extract nutrition supplement) and Sanmeitan.
Launched Flunarl, an agent to treat cerebrovascular disorders.
1983
Death of the company’s founder Benzaburo Kato.
Completed Kato Memorial Bioscience Research Institute.
Received The Chemical Society of Japan’s Chemical Technical Prize for the invention of Sagamicin.
Launched SUN shochu.
1982
Completed Toxicological Research Laboratories.
Launched Sagamicin (an amino glycoside antibiotic agent), and Nauzelin (a gastroprokinetic agent).
Launched Kyowa Shochu Diya and Kyowa Shochu Maroyaka.
1981
Established the Bio Business Division.
Established Kyowa Medex Co., Ltd., which develops, produces and sells diagnostic reagents.
Established new CI mark.
Launched Sainte Neige Wine, Kainokuni.
1980
Launched EC-Doparl, an anti-Parkinson’s disease agent.
1979
Launched Desmopressin Intranasal (an agent for diabetes insipidus), Flubber (aroma-base seasonings) and Porte (brewed seasonings for bread and cake production).
1978
Established Janssen-Kyowa Co., Ltd.
Launched Glumal (an agent for digestive ulcer) and Inovan (an agent to improve acute circulatory failure).
1977
Received the Environment Agency Secretary’s Award for recycling of fermentation liquid waste and improvement of water quality.
Established Fermex for the production of feed-grade L-Lysine.
Launched Genkai and Sun shochu.
1975
Launched Adriacin, 5-FU Dry Syrup (anticancer agents), Pasetocin (a synthetic penicillin agent), Depakene (an anti-epileptic agent) and Determiner TC FC (a diagnostic reagent).
Launched High Cook (aroma-base seasonings) and Power Up (an agent to improve bread production).
1974
Established Ohland Foods Co., Ltd. to start producing and selling frozen dough for bread and cake mix.
1973
Established Kyowa Hakko Europe GmbH.
Established Kyowa Miles, a merger company with United States Miles Inc.
Established Kyowa FD Foods Co., Ltd. to produce freeze-dried foods.
1972
Launched Doparl (an anti-Parkinson’s disease agent) and Propaderm (topical medication for skin disorders).
Launched CM Kyowa, amino-acid base seasonings.
1971
Launched Apiracohl for treating hypertension, and Leunase for treating leukemia.
1970
Launched Atomolan (a reduced glutathione preparation), Aminocysin (an antibiotic agent) and Golden Arrow (a prepared mix for bread and cake).
1969
Established Kyowa Hakko U.S.A., Inc. and Pharmaceutical Research Institute.
1968
Launched Maggi Hpp, a natural seasoning.
1967
Established the Chemical Business Headquarters.
Launched AM Kyowa, an amino acid-base seasoning.
Launched 5-FU, an anticancer agent, and acetylspiramycin, an antibiotic agent.
1966
Established the Food Business Headquarters.
Established Kyowa Yuka Co., Ltd., as a separate company from Daikyowa Sekiyu Kagaku Co., Ltd.
Received The Japan Academy Prize for research on amino acid production by fermentation.
1965
Established the Pharmaceutical Business Headquarters.
Launched lysine for animal feed.
1964
Established the Alcohol & Liquor Headquarters.
Launched Glumin, a remedy for peptic ulcers.
Began distribution of KH fertilizer.
1963
Began the pharmaceutical business.
Launched Mitomycin C (an anticancer agent), and Spiramycin (an antibiotic agent).
1961
Established Daikyowa Sekiyu Kagaku Co., Ltd. through joint investment with Daikyo Sekiyu Co., Ltd.
Produced acetone butanol from petroleum.
1960
Received the Prime Minister’s Award National Commendation for Invention for the invention of the L-glutamic acid production process.
Consolidated with Japan Liquor Co., Ltd.
1959
Received the Science and Technology Agency Secretary’s Award for the invention of L-glutamic acid production process.
1958
Invented the process of L-lysine production by fermentation.
Received The Chemical Society of Japan’s Chemical Technical Prize and Okochi Memorial Prize for inventing the L-glutamic acid production process by fermentation.
Launched a plant growth regulator, Gibberellin Kyowa.
1957
Launched Carcinophyrin, an anticancer agent.
1956
Succeeded in isolating and commercially mass-producing the anticancer agent Mitomycin C.
Invented the process of L-glutamic acid production by fermentation.
1954
Bought out Sanyo Kagaku Co., Ltd.
1951
Introduced production technology of streptomycin, an anti-tubercular drug, from US pharmaceutical company Merck & Co. and succeeded in its mass production.
1950
Introduced the Arosupasu distilling system for alcohol distillation.
1949
Established Kyowa Hakko Kogyo Co., Ltd. as a secondary company of Kyowa Sangyo Co., Ltd.
1948
Started Japan’s first mass production of acetone butanol from syrup
Yup, big post here. But look at the size of this company from this excerpt alone. They even supply to Johnson and Johnson. If it is all one main source, then the tainted raw material goes out to all under different affiliate names and branding.
>>>They are spread all over the world, and it would be really difficult to find out who has what.
That is probably why there hasn’t been much exposure to the extent of this poisoning in the media.
The only thing that China has that’s vastly superior to us is the number of people. I’d bet their infrastructure rots.
The only reason corporations want to do business there is because labor is dirt cheap.
Watch out — this bag looks familiar. If anyone shops at Japanese or Asian stores, beware. I may have seen it there (Mitsuwa? The Japanese supermarkets in CA?).
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.